Table 2.
AOM Group (n = 49) | ||
---|---|---|
Antiosteoporosis Medication | Mean Duration (Months, Minimum–Maximum) | |
BP/Dmab (n = 36) | ||
Oral BPs (24) | 41.3 (1–212) | |
Injected BPs (4) | 17.5 (4–29) | |
Dmab (7) | 32.3 (2–66) | |
Sequential therapy (1) | over 12 | |
Non-BP/Dmab (n = 13) | ||
Alfacalcidol (7) | 53.0 (18–96) | |
Bazedoxifene acetate (2) | 15.5 (13–18) | |
Tamoxifen (2) | 43.0 (12–74) | |
Teriparatide (1) | 7 | |
Trastuzumab (1) | 12 |
AOM, antiosteoporosis medication.